We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
+2.27%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$107M
AUM Growth
-$11.2M
(-9.5%)
Cap. Flow
-$8.41M
Cap. Flow
% of AUM
-7.87%
Top 10 Holdings %
Top 10 Hldgs %
38.95%
Holding
106
New
22
Increased
11
Reduced
40
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VG
Vonage Holdings Corporation
VG
|
+$2.11M |
| 2 |
OptimizeRx
OPRX
|
+$1.94M |
| 3 |
Pilgrim's Pride
PPC
|
+$1.85M |
| 4 |
Children's Place
PLCE
|
+$1.75M |
| 5 |
KB Home
KBH
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.1M |
| 2 |
Genesco
GCO
|
+$2.59M |
| 3 |
NeoGenomics
NEO
|
+$2.58M |
| 4 |
Knight Transportation
KNX
|
+$2.12M |
| 5 |
POLY
Plantronics, Inc.
POLY
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.41% |
| 2 | Healthcare | 22.18% |
| 3 | Consumer Discretionary | 12.42% |
| 4 | Communication Services | 10.75% |
| 5 | Energy | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Wintrust Financial
WTFC
$10.8B
| $206K | 0.19% |
+2,816
| New | +$206K |
|
77
MKS Inc
MKSI
$20.1B
| $205K | 0.19% |
2,634
| – | – |
|
78
Ameris Bancorp
ABCB
$5.85B
| $202K | 0.19% |
+5,155
| New | +$188K |
|
|
XRN
79
Chiron Real Estate Inc
XRN
$514M
| $193K | 0.18% |
3,671
-6
| -0.2% | -$313 |
|
80
Cameco
CCJ
$37.6B
| $176K | 0.16% |
16,358
| – | – |
|
|
PCTI
81
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $164K | 0.15% |
37,022
| – | – |
|
|
SOLOW
82
DELISTED
Electrameccanica Vehicles Corp. Ltd. Warrants
SOLOW
| – | – |
-88,528
| Closed | -$63.3K |
|
83
One Stop Systems
OSS
$303M
| $28K | 0.03% |
16,165
-55,817
| -78% | -$117K |
|
84
Advanced Energy
AEIS
$11.6B
| – | – |
-12,693
| Closed | -$631K |
|
85
ATI
ATI
$25.6B
| – | – |
-9,485
| Closed | -$243K |
|
|
BRY
86
DELISTED
Berry Corp
BRY
| – | – |
-12,933
| Closed | -$149K |
|
|
87
CALL
Cameco
CCJ
$37.6B
| – | – |
-32,000
| Closed | -$377K |
|
88
CEVA Inc
CEVA
$910M
| – | – |
-21,606
| Closed | -$582K |
|
89
Designer Brands
DBI
$307M
| – | – |
-43,496
| Closed | -$966K |
|
|
90
Genesco
GCO
$425M
| – | – |
-56,904
| Closed | -$2.59M |
|
91
Korn Ferry
KFY
$4.18B
| – | – |
-30,659
| Closed | -$1.37M |
|
|
92
Knight Transportation
KNX
$11.3B
| – | – |
-64,805
| Closed | -$2.12M |
|
93
Ligand Pharmaceuticals
LGND
$5.76B
| – | – |
-12,880
| Closed | -$1.01M |
|
94
LiqTech
LIQT
$23M
| – | – |
-7,160
| Closed | -$493K |
|
95
Omnicell
OMCL
$1.61B
| – | – |
-14,033
| Closed | -$1.13M |
|
|
96
CALL
Pilgrim's Pride
PPC
$6.51B
| – | – |
-10,000
| Closed | -$223K |
|
97
QuinStreet
QNST
$890M
| – | – |
-86,757
| Closed | -$1.16M |
|
98
SM Energy
SM
$7.8B
| – | – |
-75,708
| Closed | -$1.1M |
|
99
Direxion Daily Small Cap Bear 3x ETF
TZA
$250M
| – | – |
-282
| Closed | -$1.11M |
|
|
VIVO
100
DELISTED
Meridian Bioscience Inc
VIVO
| – | – |
-13,991
| Closed | -$246K |
|
Similar funds
KA
DEA
EAN
PIP
SC
L
LB
ACM
1492 Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, 1492 Capital Management held 106 positions worth $107M, down 9.5% from $118M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
1492 Capital Management withdrew a net $8.41M in Q2 2019, closing 24 positions and reducing 40 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $5.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, 1492 Capital Management opened a new position in Pilgrim's Pride worth $1.81M.
- 1492 Capital Management's largest Q2 2019 buy was Pilgrim's Pride: 71,417 shares worth $1.81M.
- 1492 Capital Management added most to Vonage Holdings Corporation in Q2 2019, an estimated $2.11M increase.
- 1492 Capital Management's biggest Q2 2019 reduction was NeoGenomics, cutting an estimated $2.58M.
- 1492 Capital Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019, selling an estimated $5.1M.
- 1492 Capital Management's ten largest holdings make up 39% of its $107M portfolio in Q2 2019.
- 1492 Capital Management opened 22 new positions and closed 24 in Q2 2019.
- 1492 Capital Management's portfolio value fell 9.5% quarter-over-quarter to $107M.
Based on 1492 Capital Management's 13F filing for Q2 2019, filed 6 Aug 2019.